LncRNA H19 promotes keloid formation through targeting the miR-769-5p/EIF3A pathway

被引:22
作者
Xu, Lingang [1 ]
Sun, Nan [1 ]
Li, Guangshuai [1 ]
Liu, Linbo [1 ]
机构
[1] Zhengzhou Univ, Dept Plast Surg, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
关键词
Keloid; Fibroblasts; H19; miR-769-5p; EIF3A; LONG NONCODING RNAS; COLLAGEN-SYNTHESIS; FIBROBLASTS; EXPRESSION; PROLIFERATION; APOPTOSIS; TISSUE;
D O I
10.1007/s11010-020-04024-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Keloid is a skin disease characterized by fibrous hyperplasia, which is often difficult to cure. Long non-coding RNAs (lncRNAs) have been shown to be associated with the development of many diseases. However, the role and mechanism of lncRNA H19 in keloid has been less studied. Our study found that lncRNA H19 expression was increased in keloid tissues and fibroblasts. Besides, H19 knockdown hindered the proliferation, migration, invasion, extracellular matrix (ECM) deposition, and enhanced the apoptosis of keloid fibroblasts. Further experiments showed that microRNA (miR)-769-5p could be sponged by H19, and its knockdown reversed the suppression effect of H19 knockdown on keloid formation. Eukaryotic initiation factor 3A (EIF3A) was found to be a target of miR-769-5p, and its overexpression inverted the inhibition effect of miR-769-5p overexpression on keloid formation. Moreover, the expression of EIF3A was regulated by H19 and miR-769-5p in keloid fibroblasts. Collectively, LncRNA H19 might play an active role in keloid formation, which might provide a new target for the treatment of keloid.
引用
收藏
页码:1477 / 1487
页数:11
相关论文
共 31 条
[1]   Cancer associated fibroblasts: is the force the path to the dark side? [J].
Barbazan, Jorge ;
Vignjevic, Danijela Matic .
CURRENT OPINION IN CELL BIOLOGY, 2019, 56 :71-79
[2]   Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases [J].
Bhattacharjee, Oindrila ;
Ayyangar, Uttkarsh ;
Kurbet, Ambika S. ;
Ashok, Driti ;
Raghavan, Srikala .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019, 7
[3]   Quality of life of patients with keloid and hypertrophic scarring [J].
Bock, O ;
Schmid-Ott, G ;
Malewski, P ;
Mrowietz, U .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2006, 297 (10) :433-438
[4]   Collateral Damage IntendedCancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy [J].
Cavaco, Ana ;
Rezaei, Maryam ;
Niland, Stephan ;
Eble, Johannes A. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (11)
[5]   Trichostatin A inhibits collagen synthesis and induces apoptosis in keloid fibroblasts [J].
Diao, Jian-Sheng ;
Xia, Wen-Sen ;
Yi, Cheng-Gang ;
Wang, Ying-Mei ;
Li, Bing ;
Xia, Wei ;
Liu, Bei ;
Guo, Shu-Zhong ;
Sun, Xu-De .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2011, 303 (08) :573-580
[6]  
DiStefano JK, 2018, METHODS MOL BIOL, V1706, P91, DOI 10.1007/978-1-4939-7471-9_6
[7]   Keloid Scarring: Understanding the Genetic Basis, Advances, and Prospects [J].
Halim, Ahmad Sukari ;
Emami, Azadeh ;
Salahshourifar, Iman ;
Kannan, Thirumulu Ponnuraj .
ARCHIVES OF PLASTIC SURGERY-APS, 2012, 39 (03) :184-189
[8]   Long non-coding RNA HOXA11-AS induces type I collagen synthesis to stimulate keloid formation via sponging miR-124-3p and activation of Smad5 signaling [J].
Jin, Jun ;
Zhai, Hong-Feng ;
Jia, Zhen-Hua ;
Luo, Xiao-Hua .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2019, 317 (05) :C1001-C1010
[9]  
Juckett G, 2009, AM FAM PHYSICIAN, V80, P253
[10]   miR-196a Downregulation Increases the Expression of Type I and III Collagens in Keloid Fibroblasts [J].
Kashiyama, Kazuya ;
Mitsutake, Norisato ;
Matsuse, Michiko ;
Ogi, Tomoo ;
Saenko, Vladimir A. ;
Ujifuku, Kenta ;
Utani, Atsushi ;
Hirano, Akiyoshi ;
Yamashita, Shunichi .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (06) :1597-1604